These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22846787)

  • 21. Bioluminescence detection of proteolytic bond cleavage by using recombinant aequorin.
    Deo SK; Lewis JC; Daunert S
    Anal Biochem; 2000 May; 281(1):87-94. PubMed ID: 10847614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A microtiter colorimetric assay for the HIV-1 protease.
    Stebbins J; Debouck C
    Anal Biochem; 1997 Jun; 248(2):246-50. PubMed ID: 9177750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
    Pereira CF; Paridaen JT; van de Bovenkamp M; Middel J; Verhoef J; Nottet HS
    J Antimicrob Chemother; 2003 May; 51(5):1181-9. PubMed ID: 12668583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains.
    Miller JF; Furfine ES; Hanlon MH; Hazen RJ; Ray JA; Robinson L; Samano V; Spaltenstein A
    Bioorg Med Chem Lett; 2004 Feb; 14(4):959-63. PubMed ID: 15013001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.
    Toor JS; Sharma A; Kumar R; Gupta P; Garg P; Arora SK
    Antiviral Res; 2011 Nov; 92(2):213-8. PubMed ID: 21875619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
    Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunoenzymatic solid-phase assay for quantitative determination of HIV-1 protease activity.
    Gutiérrez OA; Salas E; Hernández Y; Lissi EA; Castrillo G; Reyes O; Garay H; Aguilar A; García B; Otero A; Chavez MA; Duarte CA
    Anal Biochem; 2002 Aug; 307(1):18-24. PubMed ID: 12137774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.
    Martinez-Cajas JL; Wainberg MA; Oliveira M; Asahchop EL; Doualla-Bell F; Lisovsky I; Moisi D; Mendelson E; Grossman Z; Brenner BG
    J Antimicrob Chemother; 2012 Apr; 67(4):988-94. PubMed ID: 22315096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors.
    Torti C; Uccelli MC; Quiros-Roldan E; Gargiulo F; Tirelli V; Lapadula G; Regazzi M; Pierotti P; Tinelli C; De Luca A; Patroni A; Manca N; Carosi G
    J Clin Virol; 2006 Apr; 35(4):414-9. PubMed ID: 16280255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency.
    Klabe RM; Bacheler LT; Ala PJ; Erickson-Viitanen S; Meek JL
    Biochemistry; 1998 Jun; 37(24):8735-42. PubMed ID: 9628735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
    Bouzide A; Sauvé G; Yelle J
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1509-13. PubMed ID: 15713418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E; Samudrala R
    Antivir Ther; 2005; 10(1):157-66. PubMed ID: 15751773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.
    Cheng YS; Lo KH; Hsu HH; Shao YM; Yang WB; Lin CH; Wong CH
    J Virol Methods; 2006 Oct; 137(1):82-7. PubMed ID: 16849028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease.
    Park JC; Hur JM; Park JG; Hatano T; Yoshida T; Miyashiro H; Min BS; Hattori M
    Phytother Res; 2002 Aug; 16(5):422-6. PubMed ID: 12203260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Directed evolution of PDZ variants to generate high-affinity detection reagents.
    Ferrer M; Maiolo J; Kratz P; Jackowski JL; Murphy DJ; Delagrave S; Inglese J
    Protein Eng Des Sel; 2005 Apr; 18(4):165-73. PubMed ID: 15820976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.
    Lee JS; Hattori M; Kim J
    Planta Med; 2008 Apr; 74(5):532-4. PubMed ID: 18543149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
    Liu S; Boyer-Chatenet L; Lu H; Jiang S
    J Biomol Screen; 2003 Dec; 8(6):685-93. PubMed ID: 14711394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
    Cheng N; Lee SK; Donover PS; Reichman M; Schiffer CA; Hull-Ryde EA; Swanstrom R; Janzen WP
    J Lab Autom; 2014 Jun; 19(3):297-303. PubMed ID: 24305957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry.
    Meng J; Lai MT; Munshi V; Grobler J; McCauley J; Zuck P; Johnson EN; Uebele VN; Hermes JD; Adam GC
    J Biomol Screen; 2015 Jun; 20(5):606-15. PubMed ID: 25681434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.